Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Cavalry who wrote (636)	10/25/1998 2:14:00 PM
From: Michael Olin	Read Replies (1) \| Respond to of 1255

Yes, some of us longs are still out here. I bought in 4/96 at 5.875 and 8/96 at 3.375. I heard promising things about the science (and confirmed it with a biochemist or two), saw where they were with trials, and I'm still here. Partnership with a major pharmaceutical was always being discussed on the thread as a necessary step to bring the compounds through Phase III trials, NDA and to market. There was never any expectation, at least on my part, that a partnership was imminent. It was always those "by the end of the year" rumors. This year, with delisting a distinct possibility, maybe it's more urgent, also, this is the first time that the company has come out with anything directly suggesting that partnership discussions were even approaching fruition. If I have to write this one off, it will be the whole thing. I'd hate to bail out for pennies and then see it take off. I knew when I bought CORX that the stock could just as easily go to $0 as $100. I'm still waiting to see what happens next. -Michael